Anti-CD4 monoclonal antibody B-F5

Drug Profile

Anti-CD4 monoclonal antibody B-F5

Alternative Names: Anti-CD4 monoclonal antibody - Diaclone; B-F5; Monoclonal antibody B-F5

Latest Information Update: 19 Feb 2008

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Diaclone Research; OPi
  • Developer Diaclone Research
  • Class Antipsoriatics; Monoclonal antibodies
  • Mechanism of Action CD4 antigen inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Atopic dermatitis; Psoriasis; Rheumatoid arthritis

Most Recent Events

  • 15 Apr 1999 Investigation in Atopic dermatitis in France (IV-infusion)
  • 15 Apr 1999 Investigation in Psoriasis in France (IV-infusion)
  • 15 Apr 1999 Investigation in Rheumatoid arthritis in France (IV-infusion)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top